NCCTG N057K phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: A North Central Cancer Treatment Group trial.
- Citation:
- J Clin Oncol vol 30 (15 suppl) abstr 2031
- Meeting Instance:
- ASCO 2012
- Year:
- 2012
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Long-Term-Followup
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2149
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- D. Ma E. Galanis D. Schiff W. Wu P. J. Peller C. Giannini P. D. Brown J. H. Uhm S. Mcgraw K. A. Jaeckle P. J. Flynn J. C. Buckner J. N. Sarkaria
- Networks:
- Study
- NCCTG-N057K
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1,2
- Keywords: